fda approval in myeloma, label update in her2 breast cancer, and more
Published 4 years ago • 201 plays • Length 10:55
Download video MP4
Download video MP3
Similar videos
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
19:20
fda-approved therapies for relapsed/refractory her2 mbc
-
7:48
fda guidelines in male breast cancer, encouraging data in breast cancer and myeloma, and more
-
9:57
fda approvals in fl and rcc, breakthrough designation in myeloma, and more
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
5:55
fda approval in myeloma, breakthrough designations in rcc and aplastic anemia, and more
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
0:31
preview: promising phase iii myeloma and nsclc trials, fda approval sought in mzl, and more
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
-
9:31
breakthrough designation in myeloma, chmp opinions in rcc and pancreatic cancer, and more
Clip.africa.com - Privacy-policy